DOI QR코드

DOI QR Code

Simultaneous determination of amphetamine-like drugs in human urine by SPE and GC/MS

고체상추출과 GC/MS를 이용한 소변 중 암페타민계 마약성분 동시분석법

  • Cheong, Jae Chul (Drug Analysis Laboratory, Forensic Science Division, Supreme Prosecutors' Office) ;
  • Kim, Jin Young (Drug Analysis Laboratory, Forensic Science Division, Supreme Prosecutors' Office) ;
  • In, Moon Kyo (Drug Analysis Laboratory, Forensic Science Division, Supreme Prosecutors' Office) ;
  • Cheong, Won Jo (Department of Chemistry, Inha University)
  • Received : 2007.08.28
  • Accepted : 2007.11.19
  • Published : 2008.02.25

Abstract

Although liquid-liquid extraction (LLE) method has been used routinely for the analysis of amphetamine-like drugs (amphetamine; AP, methamphetamine; MA, 3,4-methylenedioxyamphetamine; MDA, 3,4-methylenedioxymethamphetamine; MDMA, 3,4-methylenedioxyethylamphetamine; MDEA), a solid-phase extraction (SPE) method, which can be automated, was applied for the simultaneous determination by GC/MS in human urine. Urine samples (3 mL) and 0.1 M phosphate buffer (1 mL, pH 7.0) were extracted by an automated SPE system. The eluent was evaporated, derivatized with trifluoroacetic anhydride (TFAA), and analyzed by GC/MS. The calibration curves was linear with correlation coefficient ($r^2$) above 0.994 in the ranges of 34.0 (AP), 28.0 (MDA)~1000.0 ng/mL for AP, MDA, and 50.0~2000.0 ng/mL for MA, MDMA, and MDEA. The limits of detection ranged from 4.0 to 10.0 ng/mL, and the limits of quantitation ranged from 12.0 to 34.0 ng/mL. The relative recoveries were 93.5~107.7 %. The precisions and accuracies were 1.9~14.8 % and -8.7~14.8 %, respectively. The present method was successfully applied to identify the MA or Ecstasy (MDMA) abusers in exact as well as rapid.

소변 중 암페타민계 5성분(amphetamine; AP, methamphetamine; MA, 3,4-methylenedioxyamphetamine; MDA, 3,4-methylenedioxymethamphetamine; MDMA, 3,4-methylenedioxyethylamphetamine; MDEA)의 동시분석을 위하여 기존의 액체상추출(liquid-liquid extraction; LLE) 방법과는 달리 감정과정의 자동화가 가능한 고체상추출(solid-phase extraction, SPE) 방법을 도입하였다. 시험관에 소변 3 mL와 0.1 M 인산완충액 1 mL (pH 7.0)를 넣고, 자동추출장치를 이용하여 추출하고, 증발 건고하여 유도체화 한 다음 GC/MS로 분석하였다. 그 결과 검정곡선의 직선성 상관계수 ($r^2$)는 AP와 MDA [농도범위 34.0 (AP), 28.0 (MDA)~1000.0 ng/mL] 및 MA, MDMA, MDEA (농도범위 50.0~2000.0 ng/mL)에서 0.994 이상으로 나타났다. 그리고 각 성분들의 검출한계 (LOD)는 4.0~10.0 ng/mL 범위였고, 정량한계 (LOQ)는 12.0~34.0 ng/mL 범위였다. 상대 회수율은 5성분 모두 93.5~107.7%로 측정되었다. 정밀도 (precision)와 정확도 (accuracy)는 각각 1.9~14.8%와 -8.7~14.8 % 범위 값을 나타냈다. 본 실험방법을 실제 남용자 소변에 적용한 결과 메스암페타민 또는 엑스터시 투약자를 신속하고 정확하게 동시에 확인할 수 있었다.

Keywords

References

  1. G. W. Kunsman, B. Levine, J. J. Kuhlman, R. L. Jones, R. O. Hughes, C. I. Fujiyama, and M. L. Smith, J. Anal. Toxicol., 20(7), 517-521(1996) https://doi.org/10.1093/jat/20.7.517
  2. J. K. Fallon, A. T. Kicman, J. A. Henry, P. J. Milligan, D. A. Cowan, and A. J. Hutt, Clin. Chem., 45(7), 1058- 1069(1999)
  3. 김진영, 서승일, 고범준, 이재일, 정재철, 서용준, 인 문교, 약학회지, 47(3), 142-147(2003)
  4. G. W. Kunsman, J. E. Manno, K. R. Cockerham, and B. R. Manno, J. Anal. Toxicol., 14(3), 149-153(1990) https://doi.org/10.1093/jat/14.3.149
  5. Z. Huang and S. Zhang, J. Chromatogr. B., 792(2), 241- 247(2003) https://doi.org/10.1016/S1570-0232(03)00269-1
  6. 대검찰청, "마약류범죄백서", 106-108, 2006
  7. C. E. Cook, A. R. Jeffcoat, J. M. Hill, D. E. Pugh, P. K. Patetta, B. M. Sadler, W. R. White, and M. Perez- Reyes, Drug Metab. Dispos., 21(4), 717-723(1993)
  8. H. H. Maurer, Ther. Drug Monit., 18(4), 465-470(1996) https://doi.org/10.1097/00007691-199608000-00027
  9. H. K. Ensslin, K. A. Kovar, and H. H. Maurer, J. Chromatogr. B., 683(2), 189-197(1996) https://doi.org/10.1016/0378-4347(96)00129-6
  10. M. Vaddevenne, H. Vandenbussche, and A. Verstraete, Acta Clin. Belgica, 55(6), 323-333(2000) https://doi.org/10.1080/17843286.2000.11754319
  11. M. R. Lee, S. C. Yu, C. L. Lin, and Y. C. Yeh, J. Anal. Toxicol., 21(4), 278-282(1997) https://doi.org/10.1093/jat/21.4.278
  12. B. K. Gan, D. Baugh, R. H. Liu, and A. S. Walia, J. Forensic. Sci., 36(5), 1331-1341(1991)
  13. C. Jurado, M. P. Gimenez, T. Soriano, M. Menendez, and M. Repetto, J. Anal. Toxicol., 24(1), 11-16(2000) https://doi.org/10.1093/jat/24.1.11
  14. P. R. Stout, C. K. Horn, and K. L. Klette, J. Anal. Toxicol., 26(5), 253-261(2002) https://doi.org/10.1093/jat/26.5.253
  15. K. L. Klette, M. H. Jamerson, C. L. Morris-Kukoski, A. R. Kettle, and J. J. Snyder, J. Anal. Toxicol., 29(7), 669-674(2005) https://doi.org/10.1093/jat/29.7.669
  16. K. L. Klette, A. R. Kettle, and M. H. Jamerson, J. Anal. Toxicol., 30(5), 319-322(2006) https://doi.org/10.1093/jat/30.5.319
  17. S. O. Pirnay, T. T. Abraham, and M. A. Huestis, Clin. Chem., 52(9), 1728-1734(2006). https://doi.org/10.1373/clinchem.2006.069054
  18. G. W. kunsman, B. Levine, J. J. Kuhlman, R. L. Jones, R. O. Hughes, C. I. Fujiyama, and M. L. Smith, J. Anal. Toxicol., 20(7), 517-521(1996) https://doi.org/10.1093/jat/20.7.517
  19. I. Kim, J. M. Oyler, E. T. Moolchan, E. J. Cone, and M. A. Huestis, Ther. Drug. Monit., 26(6), 664-672(2004) https://doi.org/10.1097/00007691-200412000-00013